MYX 7.74% $4.89 mayne pharma group limited

Analyst price targets after market update, page-41

  1. 6,633 Posts.
    lightbulb Created with Sketch. 615
    For reference, i found this in the FY16 report;
    "Research and development costs
    Expenditure on research activities is recognised as an expense in the period in which it is incurred. An intangible asset arising from development expenditure on an internal project is recognised only when the Group can demonstrate the technical feasibility of completing the intangible asset so that it will be available for use or sale, its intention to complete and its ability to use or sell the asset, how the asset will generate future economic benefits, the availability of resources to complete the development and the ability to measure reliably the expenditure attributable to the intangible asset during its development. During the year ended 30 June 2016, 46 development projects met the requirements for capitalisation (2015: 43 development projects)."
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.89
Change
-0.410(7.74%)
Mkt cap ! $416.0M
Open High Low Value Volume
$5.30 $5.30 $4.84 $1.003M 199.5K

Buyers (Bids)

No. Vol. Price($)
2 1026 $4.84
 

Sellers (Offers)

Price($) Vol. No.
$4.91 1675 1
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.